Human antimicrobial peptide LL-37 inhibits adhesion of Candida albicans by interacting with yeast cell-wall carbohydrates

PLoS ONE

Volumn 6, Issue 3, 2011, Pages

  Tsai, Pei Wen ^a   Yang, Cheng Yao ^b   Chang, Hao Teng ^c   Lan, Chung Yu ^a  

^a NATIONAL TSING HUA UNIVERSITY   (Taiwan)

^b ANIMAL TECHNOLOGY INSTITUTE TAIWAN   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOHYDRATE; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; CHITIN; GLUCAN; MANNAN; ANTIMICROBIAL PEPTIDE LL-37; CATHELICIDIN; POLYSTYRENE DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BAGG ALBINO MOUSE; BLADDER; CANDIDA ALBICANS; CELL ADHESION; CELL AGGREGATION; CELL INTERACTION; CELL SURFACE; CELL WALL; CONTROLLED STUDY; DRUG ACTIVITY; EPIDERMIS CELL; FEMALE; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; YEAST CELL; ADHESION; ANIMAL; CARBOHYDRATE METABOLISM; CYTOLOGY; DRUG EFFECT; EPIDERMIS; METABOLISM; MICROBIAL VIABILITY; MICROBIOLOGY; PROTEIN BINDING;

CANDIDA ALBICANS; FUNGI; MUS;

ADHESIVENESS; ANIMALS; CANDIDA ALBICANS; CARBOHYDRATE METABOLISM; CATHELICIDINS; CELL WALL; EPIDERMIS; HUMANS; MICE; MICROBIAL VIABILITY; POLYSTYRENES; PROTEIN BINDING; URINARY BLADDER;

EID: 79952679401     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0017755     Document Type: Article

References (69)

1. Odds FC, (1979) Candida and candidosis Maryland University Park Press.
2. Calderone RA, (2002) Candida and Candidiasis Washington DC ASM Press.
3. Kauffman CA, (2006) Fungal infections. Proc Am Thorac Soc 3: 35-40.
4. Wenzel RP, (2005) John E. Bennett Forum on Deep Mycoses Study Design 2004: Candidiasis and salvage therapy for aspergillosis. Clin Infect Dis 41 (Suppl 6): S369-370.
5. Naglik JR, Challacombe SJ, Hube B, (2003) Candida albicans secreted aspartyl proteinases in virulence and pathogenesis. Microbiol Mol Biol Rev 67: 400-428.
6. Wilson D, Thewes S, Zakikhany K, Fradin C, Albrecht A, et al. (2009) Identifying infection-associated genes of Candida albicans in the postgenomic era. FEMS Yeast Res 9: 688-700.
7. Filler SG, Sheppard DC, (2006) Fungal invasion of normally non-phagocytic host cells. PLoS Pathog 2: e129.
8. Filler SG, (2006) Candida-host cell receptor-ligand interactions. Curr Opin Microbiol 9: 333-339.
9. Tronchin G, Pihet M, Lopes-Bezerra LM, Bouchara JP, (2008) Adherence mechanisms in human pathogenic fungi. Med Mycol 46: 749-772.
10. Zhu W, Filler SG, (2010) Interactions of Candida albicans with epithelial cells. Cell Microbiol 12: 273-282.
11. Bowman SM, Free SJ, (2006) The structure and synthesis of the fungal cell wall. Bioessays 28: 799-808.
12. Doss M, White MR, Tecle T, Hartshorn KL, (2010) Human defensins and LL-37 in mucosal immunity. Journal of Leukocyte Biology 87: 79-92.
13. Steele C, Fidel PL Jr, (2002) Cytokine and chemokine production by human oral and vaginal epithelial cells in response to Candida albicans. Infect Immun 70: 577-583.
14. Dale BA, Fredericks LP, (2005) Antimicrobial peptides in the oral environment: expression and function in health and disease. Curr Issues Mol Biol 7: 119-133.
15. Feng Z, Jiang B, Chandra J, Ghannoum M, Nelson S, et al. (2005) Human beta-defensins: differential activity against candidal species and regulation by Candida albicans. J Dent Res 84: 445-450.
16. Zasloff M, (2002) Antimicrobial peptides of multicellular organisms. Nature 415: 389-395.
17. Lai Y, Gallo RL, (2009) AMPed up immunity: how antimicrobial peptides have multiple roles in immune defense. Trends Immunol 30: 131-141.
18. Hancock RE, Sahl HG, (2006) Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat Biotechnol 24: 1551-1557.
19. Brogden KA, (2005) Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat Rev Microbiol 3: 238-250.
20. Sahl HG, Pag U, Bonness S, Wagner S, Antcheva N, et al. (2005) Mammalian defensins: structures and mechanism of antibiotic activity. Journal of Leukocyte Biology 77: 466-475.
21. Park CB, Kim HS, Kim SC, (1998) Mechanism of action of the antimicrobial peptide buforin II: Buforin II kills microorganisms by penetrating the cell membrane and inhibiting cellular functions. Biochemical and Biophysical Research Communications 244: 253-257.
22. Takeshima K, Chikushi A, Lee KK, Yonehara S, Matsuzaki K, (2003) Translocation of analogues of the antimicrobial peptides magainin and buforin across human cell membranes. Journal of Biological Chemistry 278: 1310-1315.
23. Jenssen H, Hamill P, Hancock RE, (2006) Peptide antimicrobial agents. Clin Microbiol Rev 19: 491-511.
24. Zanetti M, (2004) Cathelicidins, multifunctional peptides of the innate immunity. J Leukoc Biol 75: 39-48.
25. Sorensen OE, Follin P, Johnsen AH, Calafat J, Tjabringa GS, et al. (2001) Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3. Blood 97: 3951-3959.
26. Kai-Larsen Y, Agerberth B, (2008) The role of the multifunctional peptide LL-37 in host defense. Front Biosci 13: 3760-3767.
27. Ciornei CD, Sigurdardottir T, Schmidtchen A, Bodelsson M, (2005) Antimicrobial and chemoattractant activity, lipopolysaccharide neutralization, cytotoxicity, and inhibition by serum of analogs of human cathelicidin LL-37. Antimicrob Agents Chemother 49: 2845-2850.
28. den Hertog AL, van Marle J, van Veen HA, Van't Hof W, Bolscher JG, et al. (2005) Candidacidal effects of two antimicrobial peptides: histatin 5 causes small membrane defects, but LL-37 causes massive disruption of the cell membrane. Biochem J 388: 689-695.
29. Verstrepen KJ, Klis FM, (2006) Flocculation, adhesion and biofilm formation in yeasts. Mol Microbiol 60: 5-15.
30. De Smet K, Contreras R, (2005) Human antimicrobial peptides: defensins, cathelicidins and histatins. Biotechnol Lett 27: 1337-1347.
31. Chaffin WL, (2008) Candida albicans cell wall proteins. Microbiol Mol Biol Rev 72: 495-544.
32. Andersson E, Rydengard V, Sonesson A, Morgelin M, Bjorck L, et al. (2004) Antimicrobial activities of heparin-binding peptides. Eur J Biochem 271: 1219-1226.
33. Masuoka J, (2004) Surface glycans of Candida albicans and other pathogenic fungi: physiological roles, clinical uses, and experimental challenges. Clin Microbiol Rev 17: 281-310.
34. Latge JP, (2007) The cell wall: a carbohydrate armour for the fungal cell. Mol Microbiol 66: 279-290.
35. Miyakawa Y, Kuribayashi T, Kagaya K, Suzuki M, Nakase T, et al. (1992) Role of specific determinants in mannan of Candida albicans serotype A in adherence to human buccal epithelial cells. Infect Immun 60: 2493-2499.
36. Chromek M, Slamova Z, Bergman P, Kovacs L, Podracka L, et al. (2006) The antimicrobial peptide cathelicidin protects the urinary tract against invasive bacterial infection. Nat Med 12: 636-641.
37. Samaranayake LP, Keung Leung W, Jin L, (2009) Oral mucosal fungal infections. Periodontol 2000 49: 39-59.
38. Kauffman CA, (2005) Candiduria. Clin Infect Dis 41 (Suppl 6): S371-376.
39. Bowdish DM, Davidson DJ, Scott MG, Hancock RE, (2005) Immunomodulatory activities of small host defense peptides. Antimicrob Agents Chemother 49: 1727-1732.
40. Bowdish DM, Davidson DJ, Lau YE, Lee K, Scott MG, et al. (2005) Impact of LL-37 on anti-infective immunity. J Leukoc Biol 77: 451-459.
41. Overhage J, Campisano A, Bains M, Torfs EC, Rehm BH, et al. (2008) Human host defense peptide LL-37 prevents bacterial biofilm formation. Infect Immun 76: 4176-4182.
42. Nijnik A, Hancock RE, (2009) The roles of cathelicidin LL-37 in immune defences and novel clinical applications. Curr Opin Hematol 16: 41-47.
43. Hell E, Giske CG, Nelson A, Romling U, Marchini G, (2010) Human cathelicidin peptide LL37 inhibits both attachment capability and biofilm formation of Staphylococcus epidermidis. Lett Appl Microbiol 50: 211-215.
44. Li Y, Li X, Li H, Lockridge O, Wang G, (2007) A novel method for purifying recombinant human host defense cathelicidin LL-37 by utilizing its inherent property of aggregation. Protein Expr Purif 54: 157-165.
45. Foschiatti M, Cescutti P, Tossi A, Rizzo R, (2009) Inhibition of cathelicidin activity by bacterial exopolysaccharides. Mol Microbiol 72: 1137-1146.
46. Bergsson G, Reeves EP, McNally P, Chotirmall SH, Greene CM, et al. (2009) LL-37 complexation with glycosaminoglycans in cystic fibrosis lungs inhibits antimicrobial activity, which can be restored by hypertonic saline. J Immunol 183: 543-551.
47. Shibata N, Ichikawa T, Tojo M, Takahashi M, Ito N, et al. (1985) Immunochemical study on the mannans of Candida albicans NIH A-207, NIH B-792, and J-1012 strains prepared by fractional precipitation with cetyltrimethylammonium bromide. Arch Biochem Biophys 243: 338-348.
48. Kohatsu L, Hsu DK, Jegalian AG, Liu FT, Baum LG, (2006) Galectin-3 induces death of Candida species expressing specific beta-1,2-linked mannans. J Immunol 177: 4718-4726.
49. Li RK, Cutler JE, (1993) Chemical definition of an epitope/adhesin molecule on Candida albicans. J Biol Chem 268: 18293-18299.
50. Dromer F, Chevalier R, Sendid B, Improvisi L, Jouault T, et al. (2002) Synthetic analogues of beta-1,2 oligomannosides prevent intestinal colonization by the pathogenic yeast Candida albicans. Antimicrob Agents Chemother 46: 3869-3876.
51. Chaffin WL, Lopez-Ribot JL, Casanova M, Gozalbo D, Martinez JP, (1998) Cell wall and secreted proteins of Candida albicans: identification, function, and expression. Microbiol Mol Biol Rev 62: 130-180.
52. Sandini S, La Valle R, De Bernardis F, Macri C, Cassone A, (2007) The 65 kDa mannoprotein gene of Candida albicans encodes a putative beta-glucanase adhesin required for hyphal morphogenesis and experimental pathogenicity. Cell Microbiol 9: 1223-1238.
53. Frick IM, Karlsson C, Morgelin M, Olin AI, Janjusevic R, et al. (2008) Identification of a novel protein promoting the colonization and survival of Finegoldia magna, a bacterial commensal and opportunistic pathogen. Mol Microbiol 70: 695-708.
54. Pingel LC, Kohlgraf KG, Hansen CJ, Eastman CG, Dietrich DE, et al. (2008) Human beta-defensin 3 binds to hemagglutinin B (rHagB), a non-fimbrial adhesin from Porphyromonas gingivalis, and attenuates a pro-inflammatory cytokine response. Immunol Cell Biol 86: 643-649.
55. Dietrich DE, Xiao X, Dawson DV, Belanger M, Xie H, et al. (2008) Human alpha- and beta-defensins bind to immobilized adhesins from Porphyromonas gingivalis. Infect Immun 76: 5714-5720.
56. Maisch PA, Calderone RA, (1981) Role of Surface Mannan in the Adherence of Candida-Albicans to Fibrin-Platelet Clots Formed Invitro. Infection and Immunity 32: 92-97.
57. Harris M, Mora-Montes HM, Gow NA, Coote PJ, (2009) Loss of mannosylphosphate from Candida albicans cell wall proteins results in enhanced resistance to the inhibitory effect of a cationic antimicrobial peptide via reduced peptide binding to the cell surface. Microbiology 155: 1058-1070.
58. Zaporozhets TS, Makarenkova ID, Bakunina I, Burtseva Iu V, Kusaikin MI, et al. (2010) [Inhibition of adherence of Corynebacterium diphtheriae to human buccal epithelium by glycoside hydrolases from marine hydrobiontes]. Biomed Khim 56: 351-359.
59. Wheeler RT, Kombe D, Agarwala SD, Fink GR, (2008) Dynamic, morphotype-specific Candida albicans beta-glucan exposure during infection and drug treatment. PLoS Pathog 4: e1000227.
60. Wheeler RT, Fink GR, (2006) A drug-sensitive genetic network masks fungi from the immune system. PLoS Pathog 2: e35.
61. Loit E, Hincke MT, Altosaar I, (2010) Synthetic antimicrobial peptide L8 (MHLHKTSRVTLYLL) has membrane permeabilisation and bacterial aggregation activity. Int J Antimicrob Agents 35: 410-411.
62. Tecle T, White MR, Gantz D, Crouch EC, Hartshorn KL, (2007) Human neutrophil defensins increase neutrophil uptake of influenza A virus and bacteria and modify virus-induced respiratory burst responses. J Immunol 178: 8046-8052.
63. Yang D, Biragyn A, Hoover DM, Lubkowski J, Oppenheim JJ, (2004) Multiple roles of antimicrobial defensins, cathelicidins, and eosinophil-derived neurotoxin in host defense. Annu Rev Immunol 22: 181-215.
64. Gillum AM, Tsay EY, Kirsch DR, (1984) Isolation of the Candida albicans gene for orotidine-5′-phosphate decarboxylase by complementation of S. cerevisiae ura3 and E. coli pyrF mutations. Mol Gen Genet 198: 179-182.
65. Nett J, Lincoln L, Marchillo K, Massey R, Holoyda K, et al. (2007) Putative role of beta-1,3 glucans in Candida albicans biofilm resistance. Antimicrob Agents Chemother 51: 510-520.
66. Phan QT, Myers CL, Fu Y, Sheppard DC, Yeaman MR, et al. (2007) Als3 is a Candida albicans invasin that binds to cadherins and induces endocytosis by host cells. PLoS Biol 5: e64.
67. Meletiadis J, Mouton JW, Meis JF, Bouman BA, Donnelly JP, et al. (2001) Colorimetric assay for antifungal susceptibility testing of Aspergillus species. J Clin Microbiol 39: 3402-3408.
68. Yu Y, Huang H, Feng K, Pan M, Yuan S, et al. (2007) A short-form C-type lectin from amphioxus acts as a direct microbial killing protein via interaction with peptidoglycan and glucan. J Immunol 179: 8425-8434.
69. Tseng MC, Chang YP, Chu YH, (2007) Quantitative measurements of vancomycin binding to self-assembled peptide monolayers on chips by quartz crystal microbalance. Anal Biochem 371: 1-9.